Month: December 2020

The market’s fixation with drug manufacturers involved in treating or preventing the novel coronavirus is creating opportunities for value investors. Pfizer (NYSE:PFE), through its partnership with BioNTech SE (NASDAQ:BNTX), drew in investor interest. Between November and December, PFE stock traded no lower than $34 and topped around $43. Source: Manuel Esteban / Shutterstock.com Pfizer separated
0 Comments
In today’s near-zero interest rate environment, it’s been tough for investors looking for yield. There are many high-yielding dividend stocks to buy, but with markets at all-time highs, many of them have gotten stretched when it comes to valuation. With concerns 2020’s overvalued stock market will head lower in 2021, it may not be best
0 Comments
CNBC.com’s MacKenzie Sigalos brings you the day’s top business news headlines. On today’s show, CNBC’s Eunice Yoon reports from Beijing on the state of life and commerce in China exactly one year after a Wuhan doctor first raised a flag about Covid-19. Plus, CNBC.com’s Leslie Josephs breaks down the industry outlook for airlines in 2021
0 Comments
Walmart, America’s largest grocer, launched a primary care clinic called Walmart Health, in September 2019. Analysts say the big box retailer faces several hurdles in its quest to scale up nationally with a roster of highly paid doctors and dentists. But with more than 35 million people uninsured as of 2019, and millions more with
0 Comments